Latest News & Features
Big Pharma
Malaria remains endemic in 91 countries representing half of the world’s population | Licence is key to allow rapid access to innovation for those who need it most. 15 September 2022
Americas
Law firm McGuire Woods has hired IP litigators Michael Nutter and Merritt Westcott, for its Chicago and Houston offices, respectively. 15 September 2022
Biotechnology
Kansas-based company wins block on infringing plant-based albumins | Genetically programmed rice expresses human proteins used in immunotherapy drugs, gene therapies and vaccines. 15 September 2022
article
Patent law firm EIP has opened a new regional hub in Stockholm, Sweden with a focus on the life sciences. 13 September 2022
Americas
Deal set to enable faster use of artificial intelligence in drug discovery | Planned AI models to identify novel targets and establish biomarkers of disease. 13 September 2022
Americas
Gilead had filed patent infringement proceedings lawsuit against five companies | Drug makers will receive non-exclusive licences starting from Halloween 2031. 13 September 2022
Americas
A split Federal Circuit revived a 2017 jury verdict that Teva had infringed GSK drug | Israeli pharma firm warns of threat to availability of low-cost generic medicines. 8 September 2022
article
Law firm Hogan Lovells has hired Chris Natkanski to its global regulatory and intellectual property, media, and technology practice group in Boston. 8 September 2022
Big Pharma
Illumina bid would have “stifled innovation” | EU said Illumina was the "unrivalled supplier” of next-generation sequencing systems for genetic and genomic analysis. 8 September 2022
Americas
Mylan and Edwards Lifesciences argue that the controversial rule safeguards poor-quality patents | US v Arthrex conferred increased authority to Vidal over PTAB decisions. 6 September 2022